TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
KZR

Kezar Life Sciences Inc

Healthcare · Biotechnology

0.175$ +6.1% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Balance Sheet

Kezar Life Sciences Inc (KZR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 77 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KZR
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
11 54 115 90 152 218 300 221 145 77
10 52 110 81 145 212 286 207 137 76
9.7 51 24 15 21 63 40 35 42 72
9.7 51 107 78 140 208 277 201 132 72
0.4 0.5 0.0 0.6 0.8 0.1 – 2.3 0.4 1.9
– – – 1.2 2.0 2.5 – – – –
0.9 1.5 4.6 8.1 3.4 3.3 3.4 – – –
29 80 5.9 11 11 21 30 34 28 6.6
0.7 1.5 3.3 6.0 6.4 8.2 11 18 20 6.6
– – – 0.9 1.0 1.2 2.6 3.0 8.7 2.3
0.5 0.5 0.2 0.8 2.4 2.0 2.5 8.3 3.7 0.5
– – – – – 9.6 9.8 10 5.1 –
-17 -26 109 78 141 197 270 188 117 70
-18 -26 -49 -84 -126 -181 -249 -351 -434 -491
13 13 19 19 44 53 67 73 73 7.3

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?